A Novel UC Exclusion Diet and Antibiotics for Treatment of Mild to Moderate Pediatric Ulcerative Colitis: A Prospective Open-Label Pilot Study
Background: As the microbiome plays an important role in instigating inflammation in ulcerative colitis (UC), strategies targeting the microbiome may offer an alternative therapeutic approach. The goal of the pilot trial was to evaluate the potential efficacy and feasibility of a novel UC exclusion...
Guardado en:
Autores principales: | Chen Sarbagili-Shabat, Lindsey Albenberg, Johan Van Limbergen, Naomi Pressman, Anthony Otley, Michal Yaakov, Eytan Wine, Dror Weiner, Arie Levine |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/67a29f78299a41b6b9f49197ab95dc42 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Is histological remission of ulcerative colitis achievable?
por: Oleg V. Knyazev, et al.
Publicado: (2021) -
Analysis of Endoscopic Evaluation Reliability for Ulcerative Colitis in Histological Remission
por: Mimari Kanazawa, et al.
Publicado: (2021) -
Melilotus officinalis L. Protects Ulcerative Colitis in Rats
por: Hajar Khazraei, et al.
Publicado: (2015) -
Antioxidant and Anti-Inflammatory Effects of Gel and Aqueous Extract of Melilotus officinalis L. in Induced Ulcerative Colitis: A Rattus norvegicus Model
por: Ali Reza Safarpour, et al.
Publicado: (2015) -
Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?
por: Viscido A, et al.
Publicado: (2019)